Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 17, 2020

View Archived Issues

Linking two liver cancer culprits

Functional analysis complements sequencing

Cerevance presents phase Ib data on CVN-058 for schizophrenia cognition

Lundbeck identifies new Kv3.1 potassium channel activators

Designed Cells, Chungbuk National University patent stem cell-derived exosome-rich culture medium

New phenothiazine derivative antibacterials discovered at the University of Copenhagen

Osaka University presents new histone demethylase inhibitors

New alpha-2B adrenoceptor antagonists described by Bayer

First-in-human PK data presented for ZM-H1505R, a novel HBV capsid assembly modulator

Positive 12-month data for AAV-RPGR in X-linked retinitis pigmentosa

Ependymomas may respond to PARP inhibitors

Biological E's novel COVID-19 subunit vaccine candidate enters phase I/II development

First-in-human interim results of ALN-AGT01 in patients with hypertension

Kangpu opens phase Ib/IIa study to evaluate KPG-818 in SLE

Inovio opens phase II segment of phase II/III study evaluating COVID-19 vaccine candidate INO-4800

Artelo receives clearance for phase I/II trial of ART-27.13 in cancer anorexia

FDA clears IND application for phase II study of NT-I7 plus atezolizumab in NSCLC

Phase III trial shows efficacy and safety of intravenous immunoglobulin in treating dermatomyositis

Innovent presents phase I data on IBI-302 for neovascular AMD

Bispecific 4-1BBx5T4 antibody ALG.APV-527 advancing towards clinic

IBI-188 does not show single-agent activity in phase I study, warrants further combination studies

Tofacitinib demonstrates long-term safety and efficacy in refractory dermatomyositis

FDA clears initiation of phase II trials of NBTXR-3 in HNSCC

TrippBio reports viral clearance in trial of TD-213 for mild to moderate COVID-19

HMGXB4 correlates with vascular inflammation and SMC phenotypic switching

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 3, 2026